Off-Label Use of Medications for Treatment of Benzodiazepine Use Disorder.

Abstract:

:There is a high rate of benzodiazepine use in the population. Benzodiazepines are used for multiple indications (anxiety, seizures, alcohol withdrawal, muscular relaxation and anesthesia). Benzodiazepines are also addictive substances and a non-negligible fraction of regular users will develop dependence. There is currently no approved pharmacotherapy for benzodiazepine use disorder treatment and optimal strategies for treatment are unclear. In this review, we aimed to summarize the findings on off-label pharmacologic therapy that have been used for BZD dependence. One classical approach is to provide a slow taper associated with counseling. Anti-epileptic drugs appear also to alleviate symptoms of withdrawal. The long-term strategies of maintenance therapy (with benzodiazepine) or of blocking therapy (with a GABA antagonist such as flumazenil) could provide some clinical benefit but have not yet been tested appropriately. Pregabalin appears promising and deserves further investigation. There is a clear need for more clinical trials in this area to improve care.

journal_name

Curr Pharm Des

authors

Sabioni P,Bertram J,Le Foll B

doi

10.2174/1381612821666150619092039

subject

Has Abstract

pub_date

2015-01-01 00:00:00

pages

3306-10

issue

23

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-68139

journal_volume

21

pub_type

杂志文章,评审
  • Obstacles and Opportunities for Cholinergic Drug Development in the Treatment of Cognitive Disorders.

    abstract::The frequency of neuropsychiatric disorders is greater than that of cancer, cardiovascular disease, and diabetes combined, and is growing at a faster rate than any other ailments in the United States or Europe. Despite a considerable need for the development of treatments for central nervous system disorders, pharmace...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160127111453

    authors: Schroeder RA,Wecker L,Philpot RM

    更新日期:2016-01-01 00:00:00

  • Research Advances in Molecular Modeling in Cyclodextrins.

    abstract:BACKGROUND:Cyclodextrins (CDs), as one type of the novel pharmaceutical excipients, have been widely used in drug delivery and pharmaceutical industry. Over the past decades, a large amount of molecular modeling studies in CDs were reported for profound understanding of structural, dynamic and energetic features of CDs...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666161208142617

    authors: Zhao Q,Zhang W,Wang R,Wang Y,Ouyang D

    更新日期:2017-01-01 00:00:00

  • Microdialysis in neurointensive care.

    abstract::Microdialysis is a technique for sampling the chemistry of the interstitial fluid of tissues and organs in animal and man. It is minimally invasive and simple to perform in a clinical setting. Although microdialysis samples essentially all small molecular substances present in the interstitial fluid the use of microdi...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043384105

    authors: Ungerstedt U,Rostami E

    更新日期:2004-01-01 00:00:00

  • Oncogenic microRNAs in the genesis of leukemia and lymphoma.

    abstract::Emerging evidence has shown that microRNAs (miRNAs) can act as oncogenes in the initiation and progression of leukemia and lymphoma. Aberrant expression of oncogenic miRNAs, including miR-155, miR-17-92, miR-21, miR-125b, miR-93, miR-143-p3, miR-196b, and miR-223 promotes leukemogenesis through increasing the leukemic...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140128211724

    authors: Pan Y,Meng M,Zhang G,Han H,Zhou Q

    更新日期:2014-01-01 00:00:00

  • In silico screening for potent inhibitors against the NS3/4A protease of hepatitis C virus.

    abstract::Hepatitis C virus (HCV) infections are a serious viral health problem globally, causing liver cirrhosis and inflammation that can develop to hepatocellular carcinoma and death. Since the HCV NS3/4A protease complex cleaves the scissile peptide bond in the viral encoded polypeptide to release the non-structural protein...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/13816128113199990632

    authors: Meeprasert A,Rungrotmongkol T,Li MS,Hannongbua S

    更新日期:2014-01-01 00:00:00

  • New insights into the mechanisms of mitochondrial preconditioning-triggered neuroprotection.

    abstract::Mitochondria fulfill a number of essential cellular functions, being recognized that the strict regulation of the structure, function and turnover of these organelles is an immutable control node for the maintenance of neuronal integrity and homeostasis. Many lines of evidence posit that mitochondria constitute a conv...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211798072490

    authors: Correia SC,Cardoso S,Santos RX,Carvalho C,Santos MS,Perry G,Smith MA,Moreira PI

    更新日期:2011-01-01 00:00:00

  • Nanosuspensions of poorly water soluble drugs prepared by top-down technologies.

    abstract::In recent years, nanosuspensions have been accepted as a valuable drug delivery system for poorly water-soluble drugs. Topdown and bottom-up technologies are the two main approaches for generating nanosuspensions. Several products manufactured by the top-down technologies have been successfully commercialized demonstr...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990401

    authors: Zhang X,Li LC,Mao S

    更新日期:2014-01-01 00:00:00

  • Antiepileptic Treatment Strategy in Vascular Malformations.

    abstract:BACKGROUND:Antiepileptic treatment strategy plays an important role in the management of intracranial vascular malformations. The intracranial vascular malformations can be divided into cavernous hemangiomas, arteriovenous malformations, developmental venous anomalies and capillary telangiectasias. Seizures and hemorrh...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666171027142718

    authors: Giakoumettis D,Margetis K,Stranjalis G,Haliasos N,Papaioannou TG,Themistocleous MS

    更新日期:2017-01-01 00:00:00

  • Clinical use of aspirin in ischemic heart disease: past, present and future.

    abstract::Aspirin is an antiplatelet drug, inhibiting the cyclooxygenase activity of platelet prostaglandin H synthase-1 and almost complete suppressing platelet capacity to generate the prothrombotic and proatherogenic thromboxane A2. Antiplatelet therapy with aspirin reduces the risk of serious vascular events by about a quar...

    journal_title:Current pharmaceutical design

    pub_type: 历史文章,杂志文章,评审

    doi:10.2174/138161212803251943

    authors: De Caterina R,Renda G

    更新日期:2012-01-01 00:00:00

  • Anti-inflammatory heat shock protein 70 genes are positively associated with human survival.

    abstract::A positive relationship between stress tolerance and longevity has been observed in several model systems. That the same correlation is applicable in humans and that it may be open to experimental manipulation for extending human lifespan requires studies on association of stress genes with longevity. The involvement ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161210790883499

    authors: Singh R,Kølvraa S,Bross P,Christensen K,Bathum L,Gregersen N,Tan Q,Rattan SI

    更新日期:2010-01-01 00:00:00

  • Carnitine palmitoyltransferase: a viable target for the treatment of NIDDM?

    abstract::Inhibition of fatty acid oxidation is well recognized as a potentially effective mechanism for controlling glycemia in non-insulin-dependent diabetes mellitus (NIDDM). However, a direct targeting of inhibition of the intramitochondrial beta-oxidation pathway or an indirect modulation of fatty acid oxidation by inhibit...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Anderson RC

    更新日期:1998-02-01 00:00:00

  • Therapy against reperfusion-induced microvascular injury.

    abstract::No-reflow, i.e., the lack of distal myocardial perfusion to fully recover following recanalization of an acutely occluded coronary artery, is not only a mere consequence of ischemic injury, as substantial microvascular alterations may also develop subsequently, after initial restoration of perfusion. Since part of per...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990357

    authors: Tritto I,Zuchi C,Vitale S,Ambrosio G

    更新日期:2013-01-01 00:00:00

  • Targeting RANK/RANKL in the treatment of solid tumours and myeloma.

    abstract::Cancers which damage the human skeleton include multiple myeloma, where the primary tumour colonises bone directly, or breast and prostate cancer, where malignant cells travel from the primary tumour to form clonal outgrowths within the bone. Owing to the interaction of tumour cells with those normally found in the bo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210791034021

    authors: Buckle CH,Neville-Webbe HL,Croucher PI,Lawson MA

    更新日期:2010-01-01 00:00:00

  • Oxidative stress and antioxidants in carcinogenesis and integrative therapy of cancer.

    abstract::Oxidative stress is often considered as a causative factor in carcinogenesis. In addition, current knowledge recognizes oxidative stress as a mechanism by which various cancer therapies act against cancer. To ameliorate the side effects of cancer therapy, many of the patients suffering from cancer are subject to adjuv...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140826152822

    authors: Milkovic L,Siems W,Siems R,Zarkovic N

    更新日期:2014-01-01 00:00:00

  • Medications not intended for treatment of dyslipidemias and with a variable effect on lipids.

    abstract::Many therapeutically active medications have significant side effects, some of which can compromise the intended therapeutic goal. The development of plasma lipid abnormalities or a dyslipidemia as the result of a medication intended for an unrelated effect has been reported. Human immunodeficiency virus (HIV) infecti...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140620163023

    authors: Whayne TF,Mukherjee D

    更新日期:2014-01-01 00:00:00

  • Animal models of gastric bleeding induced by dual antiplatelet therapy using aspirin and clopidogrel--prophylactic effect of antiulcer drugs.

    abstract::We set up two models of gastric bleeding in rats using low-dose aspirin (ASA) and the antiplatelet drug clopidogrel, a P2Y₁₂ receptor antagonist, and examined the effect of antiulcer drugs on gastric bleeding and ulcerogenic responses under such conditions. Under urethane anesthesia, two catheters were inserted into t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/13816128113199990418

    authors: Takeuchi K,Izuhara C,Takayama S,Momode T,Kojo M,Hara D,Amagase K

    更新日期:2014-01-01 00:00:00

  • Pharmacological, immunological, and gene targeting of the renin-angiotensin system for treatment of cardiovascular disease.

    abstract::Effective blood pressure control with a large arsenal of conventional antihypertensive drugs, such as diuretics, beta-adrenergic blockers, and calcium channel blockers, significantly reduce the morbidity and mortality associated with cardiovascular disease. However, blood pressure control with these drugs does not red...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161207780618876

    authors: Igic R,Behnia R

    更新日期:2007-01-01 00:00:00

  • Medicinal Plants and Atherosclerosis: A Review on Molecular Aspects.

    abstract::Atherosclerosis is an inflammatory vascular disease that is characterized by progressive accumulation of cholesterol in the arterial walls and it is a major cause of cardiovascular disease. Issues related to the side effects of synthetic drugs have in recent times, led to the misuse of drugs, a lack of patient consult...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612824666180911121525

    authors: Gholipour S,Sewell RDE,Lorigooini Z,Rafieian-Kopaei M

    更新日期:2018-01-01 00:00:00

  • From 2D to 3D--a New Dimension for Modelling the Effect of Natural Products on Human Tissue.

    abstract::Natural products, or their synthetic derivatives are a treasure trove to find potential candidates for novel drugs for human treatment. The selection of diamonds from the huge pile of worthless stone is a critical--and difficult--stage in the discovery pipeline. Of all the factors to be considered, perhaps the most im...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666151002114227

    authors: Wrzesinski K,Fey SJ

    更新日期:2015-01-01 00:00:00

  • Plant- and Nutraceutical-based Approach for the Management of Diabetes and its Neurological Complications: A Narrative Review.

    abstract::Diabetes is an important metabolic disease affecting many organs and systems in the body. The nervous system is one of the body systems affected by diabetes and neuropathic complications are troublesome in diabetic patients with many consequences. As diabetes has deleterious influences almost on bodily systems, an int...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612825666191014165633

    authors: Öztürk Y,Öztürk N

    更新日期:2019-01-01 00:00:00

  • Writers and Erasers of Histone Lysine methylation with Clinically Applied Modulators: Promising Target for Cancer Therapy.

    abstract::Histone lysine methylation can be modified by various writers and erasers. Different from other epigenetic modifications, mono-, di, and tri- methylation distinctly modulate chromatin structure and thereby contribute to the regulation of DNA-based nuclear processes such as transcription, replication and repair on thei...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160715125417

    authors: Zheng YC,Ma JL,Liu Y,Liu HM

    更新日期:2016-01-01 00:00:00

  • The role of hyperglycaemia and the hypercoagulable state in the pathogenesis of cardiovascular events in diabetes mellitus: implications for hypertension management.

    abstract::Population studies have identified diabetes mellitus as a risk factor for cardiac and vascular events, with a common association with hypertension. Observational studies have consistently demonstrated blood glucose as a continuous cardiovascular risk factor. Experimental studies suggest that elevated blood glucose, th...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206776843322

    authors: Lim HS,MacFadyen RJ,Bakris G,Lip GY

    更新日期:2006-01-01 00:00:00

  • Organotin(IV) Carboxylates as Promising Potential Drug Candidates in the Field of Cancer Chemotherapy.

    abstract::Medicinal inorganic chemistry plays an important role in exploring the properties of metal ions for the designing of new drugs. The field has been stimulated by the success of cis-platin, the world best selling anticancer drug and platinum complexes with reduced toxicity, oral activity and activity against resistant t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160906143249

    authors: Sirajuddin M,Ali S

    更新日期:2016-01-01 00:00:00

  • Replication and transcription of the rotavirus genome.

    abstract::Rotaviruses are an important cause of human morbidity and mortality, representing the primary pathogens responsible for acute dehydrating diarrhea in children under the age of 3. The infectious rotavirus particle is made up of three concentric layers of protein, and contains a genome consisting of eleven segments of d...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043382620

    authors: Patton JT,Vasquez-Del Carpio R,Spencer E

    更新日期:2004-01-01 00:00:00

  • Oxygen, reactive oxygen species and tissue damage.

    abstract::The diatomic molecule of oxygen contains two uncoupled electrons and can therefore undergo reduction, yielding several different oxygen metabolites, which are collectively called Reactive Oxygen Species or ROS. They are invariably produced in aerobic environments through a variety of mechanisms, which include electron...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043384664

    authors: Bergamini CM,Gambetti S,Dondi A,Cervellati C

    更新日期:2004-01-01 00:00:00

  • Renin-angiotensin antagonists: therapeutic effects beyond blood pressure control?

    abstract::Guidelines for the treatment of hypertension allow a wide range of choices to the physicians; however some differences are present about the preferred drugs to start treatment. The most important aim remains an adequate decrease of blood pressure, something not perfectly obtained in the general population, but some cl...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212799436575

    authors: Pende A,Dallegri F

    更新日期:2012-01-01 00:00:00

  • The potential interest of topiramate in addiction.

    abstract::Topiramate is one of the currently most promising compounds in the field of addiction medicine. This paper discusses its potential utility related to a phase model of addiction development, focusing on the assumption that addiction is a continuous process involving different neurobiological pathways, depending on the ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/138161211796150864

    authors: Thorens G,Billieux J,Manghi R,Khan R,Khazaal Y,Zullino DF

    更新日期:2011-01-01 00:00:00

  • Dietary free amino acids and the gastric phase of digestion.

    abstract::In the stomach, pre-absorptive perception of food constituents is of particular importance in maintaining secretion and motility that matches the quantity and quality of nutrients. Products of food protein hydrolysis, free amino acids and short peptides, are the most potent chemical stimulants of the gastric phase of ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990581

    authors: Zolotarev VA

    更新日期:2014-01-01 00:00:00

  • Pharmacogenetics of phase I and phase II drug metabolism.

    abstract::Genetic variation in the receptors and other intracellular targets that mediate the pharmacodynamic effects of drugs can affect therapeutic outcomes. However, at present greater knowledge is available concerning the extent of gene variation in drug metabolizing enzymes that determine drug pharmacokinetics and, in turn...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210790112674

    authors: Crettol S,Petrovic N,Murray M

    更新日期:2010-01-01 00:00:00

  • Potential cardio-protective agents: A Resveratrol review (2000-2019).

    abstract::With a 2030 projection of 23.6 million deaths per year the prevalence and severity of cardiovascular disease is at an astounding high. Thus, a definitive need for the identification of novel compounds with potential to prevent or treat the disease and associated states. Moreover, there is also an ever-increasing need ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200909125354

    authors: Houacine C,Khan I,Yousaf SS

    更新日期:2020-09-09 00:00:00